The synthesis and characterization of side-chain liquid-crystalline polysiloxanes based on 4′-cyanobiphenyl-4-yl 4-{2-[2-(2-allyloxyethoxy)ethoxy]ethoxy}benzoate (11a-3), 4′-cyanobiphenyl-4-yl 4-[2-(2-allyloxyethoxy)ethoxy]benzoate (11a-2), 4′-methoxybiphenyl-4yl 4-{2-[2-(2-allyloxyethoxy)ethoxy]ethoxy}benzoate (11b-3) and 4′methoxybiphenyl-4-yl 4-[2-(2-allyloxyethoxy)ethoxy]benzoate (11b-2) and of copolysiloxanes containing structural units derived from monomer 11a-2 and 2-(2-allyloxyethoxy)ethyl methyl ether (3-2), and from monomer 11a-3 and 2-[2-(2-allyloxyethoxy)ethoxy]ethyl methyl ether (3-3), are presented. The polysiloxanes based on 11a-3 and 11a-2 display an SA mesophase, while the polysiloxanes based on 11b-3 and 11b-2 display N, and SA and N mesomorphism, respectively. All copolysiloxanes display an SA mesophase. The complexation of the polysiloxane based on the monomer 11a-3(i.e.P-11a-3) with LiCF3SO3 led to an increase in their glass-transition temperatures and a decrease in their SA-I transition temperatures. These complexes are thermotropic liquid-crystalline polyelectrolytes which can accommodate up to 0.6 mol of salt per mole of ethylene oxide repeat unit (CH2CH2O).
No takes yet. Share an insight, caveat, or question.
Percec et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: